Nutter advised Complete Health Economics Outcomes Research Solutions (“CHEORS”), a leading provider of health economics and outcomes research (HEOR) and market access services across the pharmaceutical, biotechnology, and medical device industries, in connection with its acquisition by PharmAlliance, a diversified pharmaceutical and life sciences services platform. PharmAlliance is a portfolio company of Waud Capital Partners. The Nutter team was led by Shannon Zollo and included Josh French, Ellie Myers, Francesca Oliveira, Mark Leonardo, Tracy Vitols, Scott Masaitis, Kyle Sutton, Natalie Cappellazzo, Patrick Concannon, and Erin Whitney Cicchetti.

Read more about the transaction here.

Nutter’s Corporate Department represents domestic and international corporations, publicly traded and privately-held companies, private equity firms, nonprofit institutions, and family-owned businesses in a wide variety of domestic and cross-border transactions. The firm’s attorneys advise on significant transactions in every major industry sector, including technology, life sciences, banking, professional services, real estate, energy, medical devices, health care, and manufacturing. Nutter’s corporate practice handles the full range of M&A and private equity transactions, including representing buyers and sellers in auctions processes, mergers, asset sales, stock purchases, leveraged buyouts, roll-ups, joint ventures, PIPEs, going private transactions, tender offers, and proxy contests.

About Nutter
Nutter is a Boston-based law firm that provides legal counsel to industry-leading companies, entrepreneurs, institutions, and foundations, across the country and the world. The firm’s corporate, intellectual property, litigation, real estate, employment, tax, and private client practices are national in scope. For more information, please visit and follow the firm on LinkedIn.